<DOC>
	<DOCNO>NCT03071263</DOCNO>
	<brief_summary>The purpose study determine patiromer treatment chronic kidney disease ( CKD ) subject receive spironolactone treatment resistant hypertension result persistent use spironolactone prevention hyperkalemia lead improve blood pressure control compare treatment spironolactone alone ( placebo ) .</brief_summary>
	<brief_title>Spironolactone With Patiromer Treatment Resistant Hypertension Chronic Kidney Disease</brief_title>
	<detailed_description>Approximately 290 eligible participant [ chronic kidney disease ( CKD ) stable dos medication ] randomly assign receive patiromer placebo start dose two packet day , day . All eligible participant undergo screening/run-in period ( 4 week ) determine eligibility study entry . Eligible participant randomize treated 12 week ( Treatment Period ) follow 2 week complete patiromer placebo treatment . There 8 plan clinic visit Treatment Period one plan visit two week last dose patiromer placebo ( Follow-up Period ) . The dose patiromer placebo may increase decrease ( titrate ) base participant ' individual potassium response .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperkalemia</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Age ≥ 18 year Taking least three medication blood pressure ( one diuretic ) Uncontrolled high blood pressure Abnormal kidney function ( witheGFR , measure kidney function , 25 ≤ 45 mL/min/1.73m2 Normal Blood serum Potassium specific range ( 4.3 5.1 mEq/L ) History untreated know cause high blood pressure , exclude kidney disease ( CKD ) Inability measure BP Not take high blood pressure medication prescribe medication Recent change renal function ( past 3 month ) require hospitalization dialysis Renal transplant History cancer within past 12 month Recent cardiovascular event last 3 month Clinically significant abnormality heart rhythm ( ventricular arrhythmia atrial fibrillation uncontrolled heart rate ) Inability take study medication Alcoholism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Treatment Hyperkalemia</keyword>
	<keyword>Hyperkalemia</keyword>
	<keyword>Potassium</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Resistant Hypertension</keyword>
	<keyword>Spironolactone</keyword>
</DOC>